Creating new antibodies to treat Alzheimer's disease
Developing therapeutic antibodies for Alzheimer's disease
This study is exploring new antibody treatments for Alzheimer's disease, hoping to find better ways to slow down its progression, and patients may get a chance to be part of future trials that could lead to new options for managing the condition.
Quick facts
| Grant type | Sbir 1 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Versapeutics INC NIH-funded |
| Lab location | 1 site (San Diego, United States) |
| Project ID | NIH-10821560 on NIH RePORTER |
What this research studies
This research focuses on developing innovative therapeutic antibodies aimed at treating Alzheimer's disease, a condition that currently lacks effective therapies to slow its progression. The project involves conducting preclinical studies to evaluate the pharmacokinetics and pharmacology of these novel drug candidates. By understanding how these antibodies interact within the body, the research aims to lay the groundwork for future clinical trials. Patients may have the opportunity to participate in studies that could lead to new treatment options for Alzheimer's.
Who could benefit from this research
Good fit: Ideal candidates for this research are adults aged 21 and older who are diagnosed with Alzheimer's disease.
Not a fit: Patients with other forms of dementia or cognitive impairment unrelated to Alzheimer's disease may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to new therapies that significantly slow the progression of Alzheimer's disease.
How similar studies have performed: Previous research has shown promise in developing therapeutic antibodies for neurodegenerative diseases, indicating potential for success in this area.
Where this research is happening
San Diego, United States
- Versapeutics INC — San Diego, United States (Active)
Researchers
- Principal investigator: Sun, Miao — Versapeutics INC
- Study coordinator: Sun, Miao
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.